好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2026 Annual Meeting | NeuroLeadership: Assessing Your Strengths for Strategic Career Growth in Neurology

Monday 04/20/26
12:00 PM - 01:00 PM CDT Add To Calendar
Chelsea Ochoa
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Hubs (Leadership University)
Hope M. O'Brien, MD, MBA, FAAN
Leadership
This course is designed for neurologists and neuroscience professionals who are considering a transition into leadership roles within academic medicine, private practice, hospital administration, or industry.

Identify and evaluate your leadership style and how it aligns with new opportunities.
Perform a personal SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis.
Develop a customized leadership development roadmap.
Understand how to apply neuroscience principles to organizational leadership challenges.
No CME available
Interpersonal and Communication Skills, Professionalism, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Introductory
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist
Didactic, Audience Participation
Event Timeline
12:00 PM - 01:00 PM CDT Speaker NeuroLeadership: Assessing Your Strengths for Strategic Career Growth in Neurology
Hope M. O'Brien, MD, MBA, FAAN, Lauren D. Strauss, DO, Bert B. Vargas, MD, FAAN, Madeline A. Chadehumbe, MD, FAAN
12:00 PM - 12:10 PM CDT Introduction Course overview and introduction of speakers
Hope M. O'Brien, MD, MBA, FAAN
12:10 PM - 12:25 PM CDT Speaker Leadership Self-Assessment Tools
Lauren D. Strauss, DO
12:25 PM - 12:40 PM CDT Speaker Positioning yourself as a neurology thought leader.
Bert B. Vargas, MD, FAAN
12:40 PM - 12:50 PM CDT Speaker Crafting a 90-day Plan for a New Role
12:50 PM - 01:00 PM CDT Q&A Questions for the panel
Faculty Disclosures
Hope M. O'Brien, MD, MBA, FAAN The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. An immediate family member of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zenica. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Scilex. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. O'Brien has received research support from Abbvie. The institution of Dr. O'Brien has received research support from Eli Lilly. The institution of Dr. O'Brien has received research support from IPSEN. The institution of Dr. O'Brien has received research support from Merz. Dr. O'Brien has received publishing royalties from a publication relating to health care. Dr. O'Brien has a non-compensated relationship as a Accreditation Council Member with UCNS that is relevant to AAN interests or activities.
Lauren D. Strauss, DO Dr. Strauss has a non-compensated relationship as a Secretary with Southern Headache Society that is relevant to AAN interests or activities.
Bert B. Vargas, MD, FAAN Dr. Vargas has received personal compensation for serving as an employee of Lilly USA. Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Football League. Dr. Vargas has or had stock in Eli Lilly. An immediate family member of Dr. Vargas has or had stock in Pfizer.Dr. Vargas has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League. Dr. Vargas has received personal compensation in the range of $10,000-$49,999 for serving as a Neurotrauma Consultant with National Association for Stock Car Auto Racing.
Madeline A. Chadehumbe, MD, FAAN Dr. Chadehumbe has nothing to disclose.